AI-generated summary
This systematic review of 11 included studies (nine retrospective, one prospective, one case series) assessed photobiomodulation as an add-on to treatment for medication-related osteonecrosis of the jaw. The authors report that most studies showed significant improvement when photobiomodulation was used as an adjunct, while still recommending surgical intervention for complete healing of lesions.
- Participants
- 759
- Studies included
- 11
- Who or what was studied
- Patients with medication-related osteonecrosis of the jaw; mean age 54 to 74 years, with females the most frequent gender and stage II the most frequent stage.
- Limits stated in the abstract
- The included evidence is largely retrospective, with only one prospective study and one case series, and the abstract does not report certainty of evidence or risk of bias results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Risk of bias. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.